{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:27:37Z","timestamp":1792193257339,"version":"4.4.0"},"reference-count":149,"publisher":"Bentham Science Publishers Ltd.","issue":"28","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Mitochondria are dynamic organelles essential for energy metabolism and\ncellular homeostasis, playing critical roles in ATP production, calcium regulation, redox balance,\nand apoptosis. However, mitochondrial dysfunction is a central factor in the pathogenesis of neurodegenerative\ndiseases, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's\ndisease, and Parkinson's disease. Given the essential role of mitochondria in neuronal survival,\ntargeted therapeutic strategies that restore mitochondrial function have gained significant attention.\nThis review explores the latest advances in mitochondrial-targeted therapies and their potential\napplications in neurodegenerative diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature review was conducted on mitochondrial-targeted therapeutic\nstrategies, with a focus on nanotechnology-based drug delivery systems. The analysis includes\nvarious nanoparticle-based approaches, such as liposomes, DQAsomes, and polymeric nanoparticles,\nwhich have demonstrated high biocompatibility, controlled drug release, and enhanced mitochondrial\ntargeting efficiency. Additionally, mitochondria-penetrating peptides and delocalized\nlipophilic cations (DLCs) are discussed for their role in improving drug localization within mitochondria\nand overcoming biological barriers, including the blood-brain barrier (BBB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Recent research shows the potential of mitochondrial-targeted antioxidants, peptides, and\nbiocompatible nanocarriers in arranging mitochondrial dysfunction and protecting neurons from\noxidative damage. Various nanoparticle-based drug delivery systems have demonstrated the ability\nto selectively target mitochondria, improving drug bioavailability, therapeutic efficacy, and neuroprotective\noutcomes in neurodegenerative diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Mitochondria-targeted therapies provide promising avenues for disease-modifying\ntreatments aimed at preserving neuronal integrity and delaying disease progression. The unique\nproperties of nanoparticles, such as their ability to enhance drug stability, facilitate controlled release,\nand achieve precise mitochondrial localization, make them valuable tools for neurodegenerative\ndisease therapy. Future research should focus on optimizing delivery systems, validating clinical\napplicability, and exploring interdisciplinary approaches to accelerate translation into effective\ntreatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115680266397447250723073446","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T13:14:08Z","timestamp":1753794848000},"page":"3251-3266","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nanotechnological Approaches for Mitochondrial Targeting in Neurodegenerative Diseases"],"prefix":"10.2174","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9387-0085","authenticated-orcid":true,"given":"Ahmet Dogan","family":"Ergin","sequence":"first","affiliation":[{"name":"Department Pharmaceutical Technology, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1126\/science.283.5407.1476","volume":"283","author":"Gray M.W.","year":"1999","unstructured":"Gray M.W.; Burger G.; Lang B.F.; Mitochondrial evolution. Science  1999,283(5407),1476-1481","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1089\/ars.2014.5952","volume":"22","author":"Apostolova N.","year":"2015","unstructured":"Apostolova N.; Victor V.M.; Molecular strategies for targeting antioxidants to mitochondria: Therapeutic implications. Antioxid Redox Signal  2015,22(8),686-729","journal-title":"Antioxid Redox Signal"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0022-5193(67)90079-3","volume":"14","author":"Sagan L.","year":"1967","unstructured":"Sagan L.; On the origin of mitosing cells. J Theor Biol  1967,14(3),225-IN6","journal-title":"J Theor Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"NS20180062","DOI":"10.1042\/NS20180062","volume":"2","author":"Gao F.","year":"2018","unstructured":"Gao F.; Zhang J.; Mitochondrial quality control and neurodegenerative diseases. Neuronal Signal  2018,2(4),NS20180062","journal-title":"Neuronal Signal"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"E293","DOI":"10.1152\/ajpendo.00394.2018","volume":"316","author":"Bond S.T.","year":"2019","unstructured":"Bond S.T.; Moody S.C.; Liu Y.; Civelek M.; Villanueva C.J.; Gregorevic P.; Kingwell B.A.; Hevener A.L.; Lusis A.J.; Henstridge D.C.; Calkin A.C.; Drew B.G.; The E3 ligase MARCH5 is a PPAR\u03b3 target gene that regulates mitochondria and metabolism in adipocytes. Am J Physiol Endocrinol Metab  2019,316(2),E293-E304","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00401-011-0921-0","volume":"123","author":"Karbowski M.","year":"2012","unstructured":"Karbowski M.; Neutzner A.; Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol  2012,123(2),157-171","journal-title":"Acta Neuropathol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1016\/j.febslet.2013.08.047","volume":"587","author":"Xu W.","year":"2013","unstructured":"Xu W.; Zhu H.; Gu M.; Luo Q.; Ding J.; Yao Y.; Chen F.; Wang Z.; DHTKD1 is essential for mitochondrial biogenesis and function maintenance. FEBS Lett  2013,587(21),3587-3592","journal-title":"FEBS Lett"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"00292","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"Klemmensen M.M.","year":"2024","unstructured":"Klemmensen M.M.; Borrowman S.H.; Pearce C.; Pyles B.; Chandra B.; Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics  2024,21(1),00292","journal-title":"Neurotherapeutics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1074\/jbc.TM117.000893","volume":"294","author":"Moehle E.A.","year":"2019","unstructured":"Moehle E.A.; Shen K.; Dillin A.; Mitochondrial proteostasis in the context of cellular and organismal health and aging. J Biol Chem  2019,294(14),5396-5407","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"10263","DOI":"10.1074\/jbc.M115.695825","volume":"291","author":"Demers-Lamarche J.","year":"2016","unstructured":"Demers-Lamarche J.; Guillebaud G.; Tlili M.; Todkar K.; B\u00e9langer N.; Grondin M.; Nguyen A.P.; Michel J.; Germain M.; Loss of mitochondrial function impairs lysosomes. J Biol Chem  2016,291(19),10263-10276","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2217\/epi.14.50","volume":"6","author":"Devall M.","year":"2014","unstructured":"Devall M.; Mill J.; Lunnon K.; The mitochondrial epigenome: A role in Alzheimer\u2019s disease? Epigenomics  2014,6(6),665-675","journal-title":"Epigenomics"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/antiox11010007","volume":"11","author":"Hyun D.H.","year":"2021","unstructured":"Hyun D.H.; Lee J.; A new insight into an alternative therapeutic approach to restore redox homeostasis and functional mitochondria in neurodegenerative diseases. Antioxidants  2021,11(1),7","journal-title":"Antioxidants"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/biomedicines9101467","volume":"9","author":"Catanesi M.","year":"2021","unstructured":"Catanesi M.; Brandolini L.; d\u2019Angelo M.; Tupone M.G.; Benedetti E.; Alfonsetti M.; Quintiliani M.; Fratelli M.; Iaconis D.; Cimini A.; Castelli V.; Allegretti M.; S-Carboxymethyl cysteine protects against oxidative stress and mitochondrial impairment in a parkinson\u2019s disease in vitro model. Biomedicines  2021,9(10),1467","journal-title":"Biomedicines"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1007\/s11064-022-03631-y","volume":"47","author":"Luo J.S.","year":"2022","unstructured":"Luo J.S.; Ning J.Q.; Chen Z.Y.; Li W.J.; Zhou R.L.; Yan R.Y.; Chen M.J.; Ding L.L.; The role of mitochondrial quality control in cognitive dysfunction in diabetes. Neurochem Res  2022,47(8),2158-2172","journal-title":"Neurochem Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2204596","DOI":"10.1002\/advs.202204596","volume":"10","author":"Zhang Q.","year":"2023","unstructured":"Zhang Q.; Song Q.; Yu R.; Wang A.; Jiang G.; Huang Y.; Chen J.; Xu J.; Wang D.; Chen H.; Gao X.; Nano\u2010brake halts mitochondrial dysfunction cascade to alleviate neuropathology and rescue alzheimer\u2019s cognitive deficits. Adv Sci  2023,10(7),2204596","journal-title":"Adv Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/cells11132049","volume":"11","author":"Zhao J.","year":"2022","unstructured":"Zhao J.; Wang X.; Huo Z.; Chen Y.; Liu J.; Zhao Z.; Meng F.; Su Q.; Bao W.; Zhang L.; Wen S.; Wang X.; Liu H.; Zhou S.; The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis. Cells  2022,11(13),2049","journal-title":"Cells"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"L962","DOI":"10.1152\/ajplung.00073.2014","volume":"306","author":"Schumacker P.T.","year":"2014","unstructured":"Schumacker P.T.; Gillespie M.N.; Nakahira K.; Choi A.M.K.; Crouser E.D.; Piantadosi C.A.; Bhattacharya J.; Mitochondria in lung biology and pathology: More than just a powerhouse. Am J Physiol Lung Cell Mol Physiol  2014,306(11),L962-L974","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jaci.2015.01.046","volume":"136","author":"Wiegman C.H.","year":"2015","unstructured":"Wiegman C.H.; Michaeloudes C.; Haji G.; Narang P.; Clarke C.J.; Russell K.E.; Bao W.; Pavlidis S.; Barnes P.J.; Kanerva J.; Bittner A.; Rao N.; Murphy M.P.; Kirkham P.A.; Chung K.F.; Adcock I.M.; Brightling C.E.; Davies D.E.; Finch D.K.; Fisher A.J.; Gaw A.; Knox A.J.; Mayer R.J.; Polkey M.; Salmon M.; Singh D.; Oxidative stress\u2013induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol  2015,136(3),769-780","journal-title":"J Allergy Clin Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"Ryan B.J.","year":"2015","unstructured":"Ryan B.J.; Hoek S.; Fon E.A.; Wade-Martins R.; Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: From familial to sporadic disease. Trends Biochem Sci  2015,40(4),200-210","journal-title":"Trends Biochem Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"Moon H.E.","year":"2015","unstructured":"Moon H.E.; Paek S.H.; Mitochondrial dysfunction in parkinson\u2019s disease. Exp Neurobiol  2015,24(2),103-116","journal-title":"Exp Neurobiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"Wallace D.C.","year":"2012","unstructured":"Wallace D.C.; Mitochondria and cancer. Nat Rev Cancer  2012,12(10),685-698","journal-title":"Nat Rev Cancer"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/med.21459","volume":"37","author":"Lleonart M.E.","year":"2017","unstructured":"Lleonart M.E.; Grodzicki R.; Graifer D.M.; Lyakhovich A.; Mitochondrial dysfunction and potential anticancer therapy. Med Res Rev  2017,37(6),1275-1298","journal-title":"Med Res Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41556-018-0139-7","volume":"20","year":"2018","unstructured":"Focusing on mitochondrial form and function. Nat Cell Biol  2018,20(7),735","journal-title":"Nat Cell Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.xphs.2023.07.020","volume":"112","author":"Ergin A.D.","year":"2023","unstructured":"Ergin A.D.; \u00dcner B.; Balc\u0131 \u015e.; Demirba\u011f \u00c7.; Benetti C.; Oltulu \u00c7.; Improving the bioavailability and efficacy of coenzyme q10 on alzheimer\u2019s disease through the arginine based proniosomes. J Pharm Sci  2023,112(11),2921-2932","journal-title":"J Pharm Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"102096","DOI":"10.1016\/j.jddst.2020.102096","volume":"61","author":"Dogan Ergin A.","year":"2021","unstructured":"Dogan Ergin A.; Bayindir Z.S.; Ozcelikay A.T.; Yuksel N.; A novel delivery system for enhancing bioavailability of S-adenosyl-l-methionine: Pectin nanoparticles-in-microparticles and their in vitro - in vivo evaluation\u2019. J Drug Deliv Sci Technol  2021,61,102096","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"12975","DOI":"10.2147\/IJN.S498099","volume":"19","author":"Zhou L.","year":"2024","unstructured":"Zhou L.; Du Y.; Shang Y.; Xiang D.; Xia X.; A novel triptolide nano-liposome with mitochondrial targeting for treatment of hepatocellular carcinoma. Int J Nanomedicine  2024,19,12975-12998","journal-title":"Int J Nanomedicine"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e2307261","DOI":"10.1002\/smll.202307261","volume":"20","author":"Zuo Q.","year":"2024","unstructured":"Zuo Q.; Lyu J.; Shen X.; Wang F.; Xing L.; Zhou M.; Zhou Z.; Li L.; Huang Y.; A less-is-more strategy for mitochondria-targeted photodynamic therapy of rheumatoid arthritis. Small  2024,20(25),e2307261","journal-title":"Small"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"116112","DOI":"10.1016\/j.ejmech.2023.116112","volume":"265","author":"Huang C.","year":"2024","unstructured":"Huang C.; Yuan Y.; Li G.; Tian S.; Hu H.; Chen J.; Liang L.; Wang Y.; Liu Y.; Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis. Eur J Med Chem  2024,265,116112","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/antiox12010130","volume":"12","author":"Mursaleen L.","year":"2023","unstructured":"Mursaleen L.; Chan S.H.Y.; Noble B.; Somavarapu S.; Zariwala M.G.; Curcumin and N-acetylcysteine nanocarriers alone or combined with deferoxamine target the mitochondria and protect against neurotoxicity and oxidative stress in a co-culture model of parkinson\u2019s disease. Antioxidants  2023,12(1),130","journal-title":"Antioxidants"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1208\/s12249-021-02016-8","volume":"22","author":"Karunanidhi P.","year":"2021","unstructured":"Karunanidhi P.; Verma N.; Kumar D.N.; Agrawal A.K.; Singh S.; Triphenylphosphonium functionalized Ficus religiosa L. extract loaded nanoparticles improve the mitochondrial function in oxidative stress induced diabetes. AAPS PharmSciTech  2021,22(5),158","journal-title":"AAPS PharmSciTech"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2403015","DOI":"10.1002\/adhm.202403015","volume":"14","author":"Li W.","year":"2025","unstructured":"Li W.; Shen L.; Fu S.; Li Y.; Huang F.; Li Q.; Lin Q.; Liu H.; Wang Q.; Chen L.; Tan H.; Li J.; Zhao Y.; Ran Y.; Hao Y.; Mitochondrial\u2010targeting mesoporous polydopamine nanoparticles for reducing kidney injury caused by depleted uranium. Adv Healthc Mater  2025,14(2),2403015","journal-title":"Adv Healthc Mater"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e2408581","DOI":"10.1002\/smll.202408581","volume":"21","author":"Qian W.","year":"2025","unstructured":"Qian W.; The Mitochondria-Targeted Micelle Inhibits Alzheimer\u2019s Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation. Small  2025,21(6),e2408581","journal-title":"Small"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"Pardridge W.M.","year":"2005","unstructured":"Pardridge W.M.; The blood-brain barrier: Bottleneck in brain drug development. NeuroRx  2005,2(1),3-14","journal-title":"NeuroRx"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s13311-018-0624-5","volume":"15","author":"Ugarte A.","year":"2018","unstructured":"Ugarte A.; Corbacho D.; Aymerich M.S.; Garc\u00eda-Osta A.; Cuadrado-Tejedor M.; Oyarzabal J.; Impact of neurodegenerative diseases on drug binding to brain tissues: From animal models to human samples. Neurotherapeutics  2018,15(3),742-750","journal-title":"Neurotherapeutics"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","volume":"30","author":"Ouyang Q.","year":"2022","unstructured":"Ouyang Q.; Meng Y.; Zhou W.; Tong J.; Cheng Z.; Zhu Q.; New advances in brain-targeting nano-drug delivery systems for Alzheimer\u2019s disease. J Drug Target  2022,30(1),61-81","journal-title":"J Drug Target"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.3390\/cells11233761","volume":"11","author":"Qiu Z.","year":"2022","unstructured":"Qiu Z.; Yu Z.; Xu T.; Wang L.; Meng N.; Jin H.; Xu B.; Novel nano-drug delivery system for brain tumor treatment. Cells  2022,11(23),3761","journal-title":"Cells"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1208\/s12248-017-0076-6","volume":"19","author":"Lochhead J.J.","year":"2017","unstructured":"Lochhead J.J.; Ronaldson P.T.; Davis T.P.; Hypoxic stress and inflammatory pain disrupt blood-brain barrier tight junctions: Implications for drug delivery to the central nervous system. AAPS J  2017,19(4),910-920","journal-title":"AAPS J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1021\/nn300240p","volume":"6","author":"Qiao R.","year":"2012","unstructured":"Qiao R.; Jia Q.; H\u00fcwel S.; Xia R.; Liu T.; Gao F.; Galla H.J.; Gao M.; Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano  2012,6(4),3304-3310","journal-title":"ACS Nano"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/ijms19103224","volume":"19","author":"Al-azzawi S.","year":"2018","unstructured":"Al-azzawi S.; Masheta D.; Guildford A.L.; Phillips G.; Santin M.; Dendrimeric poly(Epsilon-Lysine) delivery systems for the enhanced permeability of flurbiprofen across the blood-brain barrier in alzheimer\u2019s disease. Int J Mol Sci  2018,19(10),3224","journal-title":"Int J Mol Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","volume":"5","author":"Matsumoto J.","year":"2017","unstructured":"Matsumoto J.; Stewart T.; Sheng L.; Li N.; Bullock K.; Song N.; Shi M.; Banks W.A.; Zhang J.; Transmission of \u03b1-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: Another mechanism for initiation and progression of Parkinson\u2019s disease? Acta Neuropathol Commun  2017,5(1),71","journal-title":"Acta Neuropathol Commun"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.22318","volume":"68","author":"Zheng P.P.","year":"2010","unstructured":"Zheng P.P.; Romme E.; Spek P.J.; Dirven C.M.F.; Willemsen R.; Kros J.M.; Glut1\/SLC2A1 is crucial for the development of the blood\u2010brain barrier in vivo. Ann Neurol  2010,68(6),835-844","journal-title":"Ann Neurol"},{"key":"ref=42","first-page":"585","volume":"7","author":"Sakhrani N.M.","year":"2013","unstructured":"Sakhrani N.M.; Padh H.; Organelle targeting: Third level of drug targeting. Drug Des Devel Ther  2013,7,585-599","journal-title":"Drug Des Devel Ther"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1021\/acsami.6b15831","volume":"9","author":"Chen C.","year":"2017","unstructured":"Chen C.; Duan Z.; Yuan Y.; Li R.; Pang L.; Liang J.; Xu X.; Wang J.; Peptide-22 and cyclic rgd functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. ACS Appl Mater Interfaces  2017,9(7),5864-5873","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=44","first-page":"1","author":"Kim G.","year":"2023","unstructured":"Kim G.; Zhu R.; Zhang Y.; Jeon H.; Wang Y.; Fluorescent Chiral Quantum Dots to Unveil Origin-Dependent Exosome Uptake and Cargo Release. bioRxiv  2023,1-6","journal-title":"bioRxiv"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1073\/pnas.090082297","volume":"97","author":"Vander Heiden M.G.","year":"2000","unstructured":"Vander Heiden M.G.; Chandel N.S.; Li X.X.; Schumacker P.T.; Colombini M.; Thompson C.B.; Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci USA  2000,97(9),4666-4671","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"Giacomello M.","year":"2020","unstructured":"Giacomello M.; Pyakurel A.; Glytsou C.; Scorrano L.; The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol  2020,21(4),204-224","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"Weinberg S.E.","year":"2015","unstructured":"Weinberg S.E.; Chandel N.S.; Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol  2015,11(1),9-15","journal-title":"Nat Chem Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.bbabio.2008.03.029","volume":"1777","author":"Murphy M.P.","year":"2008","unstructured":"Murphy M.P.; Targeting lipophilic cations to mitochondria. Biochim Biophys Acta Bioenerg  2008,1777(7-8),1028-1031","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.apsb.2022.03.001","volume":"12","author":"Xu J.","year":"2022","unstructured":"Xu J.; Du W.; Zhao Y.; Lim K.; Lu L.; Zhang C.; Li L.; Mitochondria targeting drugs for neurodegenerative diseases\u2014Design, mechanism and application. Acta Pharm Sin B  2022,12(6),2778-2789","journal-title":"Acta Pharm Sin B"},{"key":"ref=50","first-page":"399","volume":"10","author":"Tauskela J.S.","year":"2007","unstructured":"Tauskela J.S.; MitoQ--a mitochondria-targeted antioxidant. IDrugs  2007,10(6),399-412","journal-title":"IDrugs"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1016\/j.tet.2015.09.014","volume":"71","author":"Jameson V.J.A.","year":"2015","unstructured":"Jameson V.J.A.; Cochem\u00e9 H.M.; Logan A.; Hanton L.R.; Smith R.A.J.; Murphy M.P.; Synthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants. Tetrahedron  2015,71(44),8444-8453","journal-title":"Tetrahedron"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"101606","DOI":"10.1016\/j.redox.2020.101606","volume":"36","author":"Chowdhury A.R.","year":"2020","unstructured":"Chowdhury A.R.; Zielonka J.; Kalyanaraman B.; Hartley R.C.; Murphy M.P.; Avadhani N.G.; Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon. Redox Biol  2020,36,101606","journal-title":"Redox Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpharm.2017.01.064","volume":"522","author":"Xu Y.","year":"2017","unstructured":"Xu Y.; Wang S.; Chan H.F.; Liu Y.; Li H.; He C.; Li Z.; Chen M.; Triphenylphosphonium-modified poly(ethylene glycol)-poly(\u03b5-caprolactone) micelles for mitochondria- targeted gambogic acid delivery. Int J Pharm  2017,522(1-2),21-33","journal-title":"Int J Pharm"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jconrel.2012.01.009","volume":"159","author":"Biswas S.","year":"2012","unstructured":"Biswas S.; Dodwadkar N.S.; Deshpande P.P.; Torchilin V.P.; Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release  2012,159(3),393-402","journal-title":"J Control Release"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1016\/j.biomaterials.2012.03.032","volume":"33","author":"Biswas S.","year":"2012","unstructured":"Biswas S.; Dodwadkar N.S.; Piroyan A.; Torchilin V.P.; Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials  2012,33(18),4773-4782","journal-title":"Biomaterials"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijbiomac.2020.11.129","volume":"167","author":"Lee Y.H.","year":"2021","unstructured":"Lee Y.H.; Park H.I.; Chang W.S.; Choi J.S.; Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery. Int J Biol Macromol  2021,167,35-45","journal-title":"Int J Biol Macromol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2019.12.011","volume":"318","author":"Cheng Y.","year":"2020","unstructured":"Cheng Y.; Ji Y.; Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. J Control Release  2020,318,38-49","journal-title":"J Control Release"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1039\/D0OB01305F","volume":"18","author":"Shi J.","year":"2020","unstructured":"Shi J.; Zhao D.; Li X.; Ding F.; Tang X.; Liu N.; Huang H.; Liu C.; The conjugation of rhodamine B enables carrier-free mitochondrial delivery of functional proteins. Org Biomol Chem  2020,18(35),6829-6839","journal-title":"Org Biomol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/1061186X.2010.536983","volume":"19","author":"Biswas S.","year":"2011","unstructured":"Biswas S.; Dodwadkar N.S.; Sawant R.R.; Koshkaryev A.; Torchilin V.P.; Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. J Drug Target  2011,19(7),552-561","journal-title":"J Drug Target"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ejpb.2013.06.008","volume":"85","author":"Xie C.","year":"2013","unstructured":"Xie C.; Chang J.; Hao X.D.; Yu J.M.; Liu H.R.; Sun X.; Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel. Eur J Pharm Biopharm  2013,85(3),541-549","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"112057","DOI":"10.1016\/j.jinorgbio.2022.112057","volume":"238","author":"Lv M.","year":"2023","unstructured":"Lv M.; Qian X.; Li S.; Gong J.; Wang Q.; Qian Y.; Su Z.; Xue X.; Liu H.K.; Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents. J Inorg Biochem  2023,238,112057","journal-title":"J Inorg Biochem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1039\/D0SC06885C","volume":"12","author":"Tan C.P.","year":"2021","unstructured":"Tan C.P.; Zhong Y.M.; Ji L.N.; Mao Z.W.; Phosphorescent metal complexes as theranostic anticancer agents: Combining imaging and therapy in a single molecule. Chem Sci  2021,12(7),2357-2367","journal-title":"Chem Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/membranes11050352","volume":"11","author":"Dubinin M.V.","year":"2021","unstructured":"Dubinin M.V.; Semenova A.A.; Nedopekina D.A.; Davletshin E.V.; Spivak A.Y.; Belosludtsev K.N.; Effect of f16-betulin conjugate on mitochondrial membranes and its role in cell death initiation. Membranes  2021,11(5),352","journal-title":"Membranes"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"115996","DOI":"10.1016\/j.ejmech.2023.115996","volume":"264","author":"Miao H.","year":"2024","unstructured":"Miao H.; Cui W.; Zhang T.; Zhang Y.; Zhang J.; Lou H.; Fan P.; Mitochondrial targeting derivatives of honokiol enhanced selective antitumor activity in NCI-H446 cells and decreased in vivo toxicity in Caenorhabditis elegans. Eur J Med Chem  2024,264,115996","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1039\/D3AY00660C","volume":"15","author":"Jiao S.","year":"2023","unstructured":"Jiao S.; Dong X.; Zhao W.; Meso pyridinium BODIPY-based long wavelength infrared mitochondria-targeting fluorescent probe with high photostability. Anal Methods  2023,15(26),3149-3155","journal-title":"Anal Methods"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"115975","DOI":"10.1016\/j.ejmech.2023.115975","volume":"264","author":"Wang X.","year":"2024","unstructured":"Wang X.; Zhang X.; Zheng G.; Dong M.; Huang Z.; Lin L.; Yan K.; Zheng J.; Wang J.; Mitochondria-targeted pentacyclic triterpene NIR-AIE derivatives for enhanced chemotherapeutic and chemo-photodynamic combined therapy. Eur J Med Chem  2024,264,115975","journal-title":"Eur J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1021\/acs.biochem.9b00857","volume":"59","author":"Kim S.","year":"2020","unstructured":"Kim S.; Nam H.Y.; Lee J.; Seo J.; Mitochondrion-targeting peptides and peptidomimetics: Recent progress and design principles. Biochemistry  2020,59(3),270-284","journal-title":"Biochemistry"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0124-z","volume":"50","author":"Kang Y.C.","year":"2018","unstructured":"Kang Y.C.; Son M.; Kang S.; Im S.; Piao Y.; Lim K.S.; Song M.Y.; Park K.S.; Kim Y.H.; Pak Y.K.; Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson\u2019s disease models. Exp Mol Med  2018,50(8),1-13","journal-title":"Exp Mol Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1021\/acs.biomac.3c00391","volume":"24","author":"Abe N.","year":"2023","unstructured":"Abe N.; Fujita S.; Miyamoto T.; Tsuchiya K.; Numata K.; Plant mitochondrial-targeted gene delivery by peptide\/dna micelles quantitatively surface-modified with mitochondrial targeting and membrane-penetrating peptides. Biomacromolecules  2023,24(8),3657-3665","journal-title":"Biomacromolecules"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acs.biomac.8b00323","volume":"19","author":"Yoshizumi T.","year":"2018","unstructured":"Yoshizumi T.; Oikawa K.; Chuah J.A.; Kodama Y.; Numata K.; Selective gene delivery for integrating exogenous dna into plastid and mitochondrial genomes using peptide\u2013dna complexes. Biomacromolecules  2018,19(5),1582-1591","journal-title":"Biomacromolecules"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41467-022-30185-y","volume":"13","author":"Law S.S.Y.","year":"2022","unstructured":"Law S.S.Y.; Liou G.; Nagai Y.; Gim\u00e9nez-Dejoz J.; Tateishi A.; Tsuchiya K.; Kodama Y.; Fujigaya T.; Numata K.; Polymer-coated carbon nanotube hybrids with functional peptides for gene delivery into plant mitochondria. Nat Commun  2022,13(1),2417","journal-title":"Nat Commun"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s42003-021-02730-w","volume":"4","author":"Daneshgar N.","year":"2021","unstructured":"Daneshgar N.; Baguley A.W.; Liang P.I.; Wu F.; Chu Y.; Kinter M.T.; Benavides G.A.; Johnson M.S.; Darley-Usmar V.; Zhang J.; Chan K.S.; Dai D.F.; Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants. Commun Biol  2021,4(1),1200","journal-title":"Commun Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1021\/acscentsci.3c00377","volume":"9","author":"Zhao T.","year":"2023","unstructured":"Zhao T.; He F.; Zhao K.; Yuxia L.; Li H.; Liu X.; Cen J.; Duan S.; A triple-targeted rutin-based self-assembled delivery vector for treating ischemic stroke by vascular normalization and anti-inflammation via ACE2\/Ang1-7 signaling. ACS Cent Sci  2023,9(6),1180-1199","journal-title":"ACS Cent Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"20210115","DOI":"10.1002\/EXP.20210115","volume":"1","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Yang H.; Wei D.; Zhang X.; Wang J.; Wu X.; Chang J.; Mitochondria\u2010targeted nanoparticles in treatment of neurodegenerative diseases. Exploration  2021,1(3),20210115","journal-title":"Exploration"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1038\/srep06064","volume":"4","author":"Luo G.F.","year":"2014","unstructured":"Luo G.F.; Chen W.H.; Liu Y.; Lei Q.; Zhuo R.X.; Zhang X.Z.; Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide. Sci Rep  2014,4(1),6064","journal-title":"Sci Rep"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejpb.2022.02.018","volume":"173","author":"Sena Ozbay H.","year":"2022","unstructured":"Sena Ozbay H.; Yabanoglu-Ciftci S.; Baysal I.; Gultekinoglu M.; Can Eylem C.; Ulubayram K.; Nemutlu E.; Topaloglu R.; Ozaltin F.; Mitochondria-targeted CoQ10 loaded PLGA-b-PEG-TPP nanoparticles: Their effects on mitochondrial functions of COQ8B HK-2 cells. Eur J Pharm Biopharm  2022,173,22-33","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbamem.2007.11.002","volume":"1778","author":"Yamada Y.","year":"2008","unstructured":"Yamada Y.; Akita H.; Kamiya H.; Kogure K.; Yamamoto T.; Shinohara Y.; Yamashita K.; Kobayashi H.; Kikuchi H.; Harashima H.; MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta Biomembr  2008,1778(2),423-432","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1177\/08853282211037030","volume":"36","author":"Ye L.","year":"2022","unstructured":"Ye L.; Yao Q.; Xu F.; He L.; Ding J.; Xiao R.; Ding L.; Luo B.; Preparation and antitumor activity of triphenylphosphine-based mitochondrial targeting polylactic acid nanoparticles loaded with 7-hydroxyl coumarin. J Biomater Appl  2022,36(6),1064-1075","journal-title":"J Biomater Appl"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"103819","DOI":"10.1016\/j.drudis.2023.103819","volume":"29","author":"Khan M.S.","year":"2024","unstructured":"Khan M.S.; Jaswanth Gowda B.H.; Almalki W.H.; Singh T.; Sahebkar A.; Kesharwani P.; Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment. Drug Discov Today  2024,29(1),103819","journal-title":"Drug Discov Today"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mito.2020.09.008","volume":"55","author":"Yamada Y.","year":"2020","unstructured":"Yamada Y.; Maruyama M.; Kita T.; Usami S.; Kitajiri S.; Harashima H.; The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease\u2019s cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activity. Mitochondrion  2020,55,134-144","journal-title":"Mitochondrion"},{"key":"ref=81","first-page":"13","volume":"2275","author":"Weissig V.","year":"2021","unstructured":"Weissig V.; Lozoya M.; Yu N.; D\u2019Souza G.;   2021,2275,13-25"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"16288","DOI":"10.1073\/pnas.1210096109","volume":"109","author":"Marrache S.","year":"2012","unstructured":"Marrache S.; Dhar S.; Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci USA  2012,109(40),16288-16293","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"e1903296","DOI":"10.1002\/smll.201903296","volume":"15","author":"Juang V.","year":"2019","unstructured":"Juang V.; Chang C.H.; Wang C.S.; Wang H.E.; Lo Y.L.; pH-responsive PEG-shedding and targeting peptide-modified nanoparticles for dual-delivery of irinotecan and microRNA to enhance tumor-specific therapy. Small  2019,15(49),e1903296","journal-title":"Small"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/polym14122510","volume":"14","author":"Perumal S.","year":"2022","unstructured":"Perumal S.; Atchudan R.; Lee W.; A review of polymeric micelles and their applications. Polymers  2022,14(12),2510","journal-title":"Polymers"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1023\/A:1011991307631","volume":"15","author":"Weissig V.","year":"1998","unstructured":"Weissig V.; Lasch J.; Erdos G.; Meyer H.W.; Rowe T.C.; Hughes J.; DQAsomes: A novel potential drug and gene delivery system made from Dequalinium. Pharm Res  1998,15(2),334-337","journal-title":"Pharm Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1515\/BC.1999.080","volume":"380","author":"Lasch J.","year":"1999","unstructured":"Lasch J.; Meye A.; Taubert H.; Koelsch R.; Mansa-ard J.; Weissig V.; Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack. Biol Chem  1999,380(6),647-652","journal-title":"Biol Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1900195","DOI":"10.1002\/ppsc.201900195","volume":"36","author":"Mendiratta S.","year":"2019","unstructured":"Mendiratta S.; Hussein M.; Nasser H.A.; Ali A.A.A.; Multidisciplinary role of mesoporous silica nanoparticles in brain regeneration and cancers: From crossing the blood\u2013brain barrier to treatment. Part Part Syst Charact  2019,36(9),1900195","journal-title":"Part Part Syst Charact"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.1002\/anie.201901699","volume":"58","author":"Yuan P.","year":"2019","unstructured":"Yuan P.; Mao X.; Wu X.; Liew S.S.; Li L.; Yao S.Q.; Mitochondria\u2010targeting, intracellular delivery of native proteins using biodegradable silica nanoparticles. Angew Chem Int Ed  2019,58(23),7657-7661","journal-title":"Angew Chem Int Ed"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1021\/acsbiomaterials.2c00865","volume":"8","author":"D\u00edaz-Garc\u00eda D.","year":"2022","unstructured":"D\u00edaz-Garc\u00eda D.; Ferrer-Donato \u00c1.; M\u00e9ndez-Arriaga J.M.; Cabrera-Pinto M.; D\u00edaz-S\u00e1nchez M.; Prashar S.; Fernandez-Martos C.M.; G\u00f3mez-Ruiz S.; Design of mesoporous silica nanoparticles for the treatment of amyotrophic lateral sclerosis (ALS) with a therapeutic cocktail based on leptin and pioglitazone. ACS Biomater Sci Eng  2022,8(11),4838-4849","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"110736","DOI":"10.1016\/j.matdes.2022.110736","volume":"219","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Qiao L-L.; Zhang Z-Q.; Liu Y-F.; Li L-S.; Shen H.; Zhao M-X.; A mitochondrial-targetable fluorescent probe based on high-quality InP quantum dots for the imaging of living cells. Mater Des  2022,219(567),110736","journal-title":"Mater Des"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"2000085","DOI":"10.1002\/adpr.202000085","volume":"2","author":"Zhang Z-Q.","year":"2021","unstructured":"Zhang Z-Q.; Ren B.; Qiao L-L.; Zhang Y-B.; Liu Y-F.; Xu J-J.; Yang X.; Zhao M-X.; Development of a Mitochondrially Targeted Probe Based on Polyethyleneimine-(3-carboxypropyl) Triphenylphosphine-Modified Quantum Dots for Fluorescence Imaging. Adv Photo Res  2021,2(2),2000085","journal-title":"Adv Photo Res"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.irn.2016.05.003","volume":"130","author":"Male D.","year":"2016","unstructured":"Male D.; Gromnicova R.; McQuaid C.;  International Review of Neurobiology  2016,130,155-198","journal-title":"International Review of Neurobiology"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.4103\/1673-5374.313040","volume":"16","author":"Silveira P.L.","year":"2021","unstructured":"Silveira P.L.; Silveira G.B.; Muller A.P.; Machado-de-\u00c1vila R.A.; Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: New perspectives. Neural Regen Res  2021,16(12),2425-2426","journal-title":"Neural Regen Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuro.2022.12.011","volume":"95","author":"Wang G.","year":"2023","unstructured":"Wang G.; Shen X.; Song X.; Wang N.; Wo X.; Gao Y.; Protective mechanism of gold nanoparticles on human neural stem cells injured by \u03b2-amyloid protein through miR-21\u20135p\/SOCS6 pathway. Neurotoxicology  2023,95,12-22","journal-title":"Neurotoxicology"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/cdd.2014.72","volume":"21","author":"Dowding J.M.","year":"2014","unstructured":"Dowding J.M.; Song W.; Bossy K.; Karakoti A.; Kumar A.; Kim A.; Bossy B.; Seal S.; Ellisman M.H.; Perkins G.; Self W.T.; Bossy-Wetzel E.; Cerium oxide nanoparticles protect against A\u03b2-induced mitochondrial fragmentation and neuronal cell death. Cell Death Differ  2014,21(10),1622-1632","journal-title":"Cell Death Differ"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/nnm-2016-0399","volume":"12","author":"Naz S.","year":"2017","unstructured":"Naz S.; Beach J.; Heckert B.; Tummala T.; Pashchenko O.; Banerjee T.; Santra S.; Cerium oxide nanoparticles: A \u2018radical\u2019 approach to neurodegenerative disease treatment. Nanomedicine  2017,12(5),545-553","journal-title":"Nanomedicine"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"43","DOI":"10.56082\/annalsarscibio.2020.2.43","volume":"9","author":"Mavroudis I.","year":"2020","unstructured":"Mavroudis I.; Petridis F.; Kazis D.; Njau S.; Costa V.; Baloyannis S.; Dentritic, spinal and mitochondrial alternations in alzheimer\u2019s desease. a preliminary descriptive study. Ann Acad Roma Scient Ser Biol Sci  2020,9(2),43-49","journal-title":"Ann Acad Roma Scient Ser Biol Sci"},{"key":"ref=98","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.84881","author":"Baloyannis S.J.","year":"2019","unstructured":"Baloyannis S.J.; Mitochondria and alzheimer\u2019s disease: An electron microscopy study. Redirecting Alzheimer Strategy - Tracing Memory Loss to Self Pathology  2019","journal-title":"Redirecting Alzheimer Strategy - Tracing Memory Loss to Self Pathology"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"925050","DOI":"10.4061\/2011\/925050","volume":"2011","author":"Pagani L.","year":"2011","unstructured":"Pagani L.; Eckert A.; Amyloid-beta interaction with mitochondria. Int J Alzheimers Dis  2011,2011(1),925050","journal-title":"Int J Alzheimers Dis"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.33786\/JCPR.2019.v09i03.017","volume":"9","author":"Vivek Sharma","year":"2019","unstructured":"Vivek Sharma ; Priyanka Nagu ; Raneev Thakur ; Pankaj Sharma ; Harish Kumar, ; Amyloid beta mediated mitochondrial dysfunction in alzheimer\u2019s disease: A mini review. J Curr Pharma Res  2019,9(3),2981-2990","journal-title":"J Curr Pharma Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1089\/ars.2011.4149","volume":"16","author":"Swerdlow R.H.","year":"2012","unstructured":"Swerdlow R.H.; Mitochondria and cell bioenergetics: Increasingly recognized components and a possible etiologic cause of Alzheimer\u2019s disease. Antioxid Redox Signal  2012,16(12),1434-1455","journal-title":"Antioxid Redox Signal"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbadis.2011.01.007","volume":"1812","author":"Calkins M.J.","year":"2011","unstructured":"Calkins M.J.; Reddy P.H.; Biochimica et biophysica acta (Bba) -. Molec Basis Dis  2011,1812(4),507-513","journal-title":"Molec Basis Dis"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ebiom.2015.03.009","volume":"2","author":"Zhang L.","year":"2015","unstructured":"Zhang L.; Zhang S.; Maezawa I.; Trushin S.; Minhas P.; Pinto M.; Jin L.W.; Prasain K.; Nguyen T.D.T.; Yamazaki Y.; Kanekiyo T.; Bu G.; Gateno B.; Chang K.O.; Nath K.A.; Nemutlu E.; Dzeja P.; Pang Y.P.; Hua D.H.; Trushina E.; Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer\u2019s Disease. EBioMedicine  2015,2(4),294-305","journal-title":"EBioMedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.3390\/ijms222111520","volume":"22","author":"Johri A.","year":"2021","unstructured":"Johri A.; Disentangling mitochondria in alzheimer\u2019s disease. Int J Mol Sci  2021,22(21),11520","journal-title":"Int J Mol Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.2147\/IJN.S144545","volume":"12","author":"Bhatt P.","year":"2017","unstructured":"Bhatt P.; Verma A.; Al-Abassi F.; Anwar F.; Kumar V.; Panda B.; Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of A\u03b240 plaques in Alzheimer\u2019s disease. Int J Nanomedicine  2017,12,8749-8768","journal-title":"Int J Nanomedicine"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1038\/s41467-020-19547-6","volume":"11","author":"Cen X.","year":"2020","unstructured":"Cen X.; Chen Y.; Xu X.; Wu R.; He F.; Zhao Q.; Sun Q.; Yi C.; Wu J.; Najafov A.; Xia H.; Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer\u2019s disease mouse model. Nat Commun  2020,11(1),5731","journal-title":"Nat Commun"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/cells9010150","volume":"9","author":"Cai Q.","year":"2020","unstructured":"Cai Q.; Jeong Y.Y.; Mitophagy in Alzheimer\u2019s Disease and Other Age-Related Neurodegenerative Diseases. Cells  2020,9(1),150","journal-title":"Cells"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbadis.2013.11.009","volume":"1842","author":"Gan X.","year":"2014","unstructured":"Gan X.; Huang S.; Wu L.; Wang Y.; Hu G.; Li G.; Zhang H.; Yu H.; Swerdlow R.H.; Chen J.X.; Yan S.S.; Biochimica ET biophysica acta (Bba) -. Molec Basis Dis  2014,1842(2),220-231","journal-title":"Molec Basis Dis"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.gendis.2016.05.001","volume":"3","author":"Wang J.","year":"2016","unstructured":"Wang J.; Chen G.J.; Mitochondria as a therapeutic target in Alzheimer\u2019s disease. Genes Dis  2016,3(3),220-227","journal-title":"Genes Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40263-019-00658-8","volume":"33","author":"Lanzillotta C.","year":"2019","unstructured":"Lanzillotta C.; Di Domenico F.; Perluigi M.; Butterfield D.A.; Targeting mitochondria in alzheimer disease: Rationale and perspectives. CNS Drugs  2019,33(10),957-969","journal-title":"CNS Drugs"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","volume":"108","author":"Gao C.","year":"2020","unstructured":"Gao C.; Wang Y.; Sun J.; Han Y.; Gong W.; Li Y.; Feng Y.; Wang H.; Yang M.; Li Z.; Yang Y.; Gao C.; Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice. Acta Biomater  2020,108,285-299","journal-title":"Acta Biomater"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2174\/1570159X05666220908100545","volume":"21","author":"Khan M.M.","year":"2023","unstructured":"Khan M.M.; Paez H.G.; Pitzer C.R.; Alway S.E.; The therapeutic potential of mitochondria transplantation therapy in neurodegenerative and neurovascular disorders. Curr Neuropharmacol  2023,21(5),1100-1116","journal-title":"Curr Neuropharmacol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"70004","DOI":"10.1111\/cbdd.70004","volume":"104","author":"Singh Y.P.","year":"2024","unstructured":"Singh Y.P.; Prasad S.; Kumar H.; A comprehensive analysis on galantamine based hybrids for the management of alzheimer\u2019s disease. Chem Biol Drug Des  2024,104(5),70004","journal-title":"Chem Biol Drug Des"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"14638","DOI":"10.1111\/cbdd.14638","volume":"104","author":"Singh Y.P.","year":"2024","unstructured":"Singh Y.P.; Kumar H.; Recent advances in medicinal chemistry of memantine against alzheimer\u2019s disease. Chem Biol Drug Des  2024,104(4),14638","journal-title":"Chem Biol Drug Des"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"14478","DOI":"10.1111\/cbdd.14478","volume":"103","author":"Singh Y.P.","year":"2024","unstructured":"Singh Y.P.; Kumar H.; A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer\u2019s disease. Chem Biol Drug Des  2024,103(2),14478","journal-title":"Chem Biol Drug Des"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/cbdd.14337","volume":"102","author":"Singh Y.P.","year":"2023","unstructured":"Singh Y.P.; Kumar H.; Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review. Chem Biol Drug Des  2023,102(6),1592-1603","journal-title":"Chem Biol Drug Des"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"Dawson T.M.","year":"2003","unstructured":"Dawson T.M.; Dawson V.L.; Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science  2003,302(5646),819-822","journal-title":"Science"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"Exner N.","year":"2012","unstructured":"Exner N.; Lutz A.K.; Haass C.; Winklhofer K.F.; Mitochondrial dysfunction in Parkinson\u2019s disease: Molecular mechanisms and pathophysiological consequences. EMBO J  2012,31(14),3038-3062","journal-title":"EMBO J"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"172617","DOI":"10.1016\/j.ejphar.2019.172617","volume":"861","author":"Ren K.D.","year":"2019","unstructured":"Ren K.D.; Liu W.N.; Tian J.; Zhang Y.Y.; Peng J.J.; Zhang D.; Li N.S.; Yang J.; Peng J.; Luo X.J.; Mitochondrial E3 ubiquitin ligase 1 promotes brain injury by disturbing mitochondrial dynamics in a rat model of ischemic stroke. Eur J Pharmacol  2019,861,172617","journal-title":"Eur J Pharmacol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0349-x","volume":"15","author":"Park J.H.","year":"2020","unstructured":"Park J.H.; Burgess J.D.; Faroqi A.H.; DeMeo N.N.; Fiesel F.C.; Springer W.; Delenclos M.; McLean P.J.; Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway. Mol Neurodegener  2020,15(1),5","journal-title":"Mol Neurodegener"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2047-9158-2-20","volume":"2","author":"Braidy N.","year":"2013","unstructured":"Braidy N.; Gai W.P.; Xu Y.H.; Sachdev P.; Guillemin G.J.; Jiang X.M.; Ballard J.W.O.; Horan M.P.; Fang Z.M.; Chong B.H.; Chan D.Y.; Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts. Transl Neurodegener  2013,2(1),20","journal-title":"Transl Neurodegener"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"Reeve A.K.","year":"2015","unstructured":"Reeve A.K.; Ludtmann M.H.; Angelova P.R.; Simcox E.M.; Horrocks M.H.; Klenerman D.; Gandhi S.; Turnbull D.M.; Abramov A.Y.; Aggregated \u03b1-synuclein and complex I deficiency: Exploration of their relationship in differentiated neurons. Cell Death Dis  2015,6(7),1820","journal-title":"Cell Death Dis"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"Hauser D.N.","year":"2013","unstructured":"Hauser D.N.; Hastings T.G.; Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis  2013,51,35-42","journal-title":"Neurobiol Dis"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/601587","volume":"2013","author":"Matsuda S.","year":"2013","unstructured":"Matsuda S.; Kitagishi Y.; Kobayashi M.; Function and characteristics of PINK1 in mitochondria. Oxid Med Cell Longev  2013,2013,1-6","journal-title":"Oxid Med Cell Longev"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"0154544","DOI":"10.1371\/journal.pone.0154544","volume":"11","author":"Murtaza M.","year":"2016","unstructured":"Murtaza M.; Shan J.; Matigian N.; Todorovic M.; Cook A.L.; Ravishankar S.; Dong L.F.; Neuzil J.; Silburn P.; Mackay-Sim A.; Mellick G.D.; Wood S.A.; Rotenone susceptibility phenotype in olfactory derived patient cells as a model of idiopathic parkinson\u2019s disease. PLoS One  2016,11(4),0154544","journal-title":"PLoS One"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"101035","DOI":"10.1016\/j.bbrep.2021.101035","volume":"27","author":"Abrahams S.","year":"2021","unstructured":"Abrahams S.; Miller H.C.; Lombard C.; van der Westhuizen F.H.; Bardien S.; Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson\u2019s disease and healthy control fibroblasts. Biochem Biophys Rep  2021,27,101035","journal-title":"Biochem Biophys Rep"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00221-016-4836-9","volume":"235","author":"Melo T.Q.","year":"2017","unstructured":"Melo T.Q.; van Zomeren K.C.; Ferrari M.F.R.; Boddeke H.W.G.M.; Copray J.C.V.M.; Impairment of mitochondria dynamics by human A53T \u03b1-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson\u2019s disease. Exp Brain Res  2017,235(3),731-742","journal-title":"Exp Brain Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"Di Maio R.","year":"2016","unstructured":"Di Maio R.; Barrett P.J.; Hoffman E.K.; Barrett C.W.; Zharikov A.; Borah A.; Hu X.; McCoy J.; Chu C.T.; Burton E.A.; Hastings T.G.; Greenamyre J.T.; \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med  2016,8(342),342ra78","journal-title":"Sci Transl Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1365-2362.2010.02354.x","volume":"40","author":"Burbulla L.F.","year":"2010","unstructured":"Burbulla L.F.; Krebiehl G.; Kr\u00fcger R.; Balance is the challenge \u2013 The impact of mitochondrial dynamics in Parkinson\u2019s disease. Eur J Clin Invest  2010,40(11),1048-1060","journal-title":"Eur J Clin Invest"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"Tysnes O.B.","year":"2017","unstructured":"Tysnes O.B.; Storstein A.; Epidemiology of parkinson\u2019s disease. J Neural Transm  2017,124(8),901-905","journal-title":"J Neural Transm"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00702-004-0195-y","volume":"112","author":"Winkler-Stuck K.","year":"2005","unstructured":"Winkler-Stuck K.; Kirches E.; Mawrin C.; Dietzmann K.; Lins H.; Wallesch C.W.; Kunz W.S.; Wiedemann F.R.; Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson?s disease. J Neural Transm  2005,112(4),499-518","journal-title":"J Neural Transm"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ng1778","volume":"38","author":"Kraytsberg Y.","year":"2006","unstructured":"Kraytsberg Y.; Kudryavtseva E.; McKee A.C.; Geula C.; Kowall N.W.; Khrapko K.; Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet  2006,38(5),518-520","journal-title":"Nat Genet"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ntt.2014.10.004","volume":"46","author":"Dai Y.","year":"2014","unstructured":"Dai Y.; Clark J.; Zheng K.; Kujoth G.C.; Prolla T.A.; Simon D.K.; Somatic mitochondrial DNA mutations do not increase neuronal vulnerability to MPTP in young POLG mutator mice. Neurotoxicol Teratol  2014,46,62-67","journal-title":"Neurotoxicol Teratol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2300758","DOI":"10.1002\/advs.202300758","volume":"10","author":"Zheng Q.","year":"2023","unstructured":"Zheng Q.; Liu H.; Zhang H.; Han Y.; Yuan J.; Wang T.; Gao Y.; Li Z.; Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of parkinson\u2019s disease. Adv Sci  2023,10(22),2300758","journal-title":"Adv Sci"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nn.3721","volume":"17","author":"Yano H.","year":"2014","unstructured":"Yano H.; Baranov S.V.; Baranova O.V.; Kim J.; Pan Y.; Yablonska S.; Carlisle D.L.; Ferrante R.J.; Kim A.H.; Friedlander R.M.; Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci  2014,17(6),822-831","journal-title":"Nat Neurosci"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"Guo X.","year":"2013","unstructured":"Guo X.; Disatnik M.H.; Monbureau M.; Shamloo M.; Mochly-Rosen D.; Qi X.; Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease\u2013associated neurodegeneration. J Clin Invest  2013,123(12),5371-5388","journal-title":"J Clin Invest"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2174\/1570159X21666230316150559","volume":"21","author":"Rahman M.M.","year":"2023","unstructured":"Rahman M.M.; Tumpa M.A.A.; Rahaman M.S.; Islam F.; Sutradhar P.R.; Ahmed M.; Alghamdi B.S.; Hafeez A.; Alexiou A.; Perveen A.; Ashraf G.M.; Emerging promise of therapeutic approaches targeting mitochondria in neurodegenerative disorders. Curr Neuropharmacol  2023,21(5),1081-1099","journal-title":"Curr Neuropharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","volume":"1822","author":"Reddy P.H.","year":"2012","unstructured":"Reddy P.H.; Shirendeb U.; Biochimica Et biophysica acta (Bba) -. Molec Basis Dis  2012,1822(2),101-110","journal-title":"Molec Basis Dis"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","volume":"23","author":"Golpich M.","year":"2017","unstructured":"Golpich M.; Amini E.; Mohamed Z.; Azman Ali R.; Mohamed Ibrahim N.; Ahmadiani A.; Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: Pathogenesis and treatment. CNS Neurosci Ther  2017,23(1),5-22","journal-title":"CNS Neurosci Ther"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","volume":"1802","author":"Moreira P.I.","year":"2010","unstructured":"Moreira P.I.; Zhu X.; Wang X.; Lee H.; Nunomura A.; Petersen R.B.; Perry G.; Smith M.A.; Mitochondria: A therapeutic target in neurodegeneration. Biochim Biophys Acta Mol Basis Dis  2010,1802(1),212-220","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"Brennan W.A.","year":"1985","unstructured":"Brennan W.A.; Bird E.D.; Aprille J.R.; Regional mitochondrial respiratory activity in Huntington\u2019s disease brain. J Neurochem  1985,44(6),1948-1950","journal-title":"J Neurochem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"Gu M.","year":"1996","unstructured":"Gu M.; Gash M.T.; Mann V.M.; Javoy-Agid F.; Cooper J.M.; Schapira A.H.V.; Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol  1996,39(3),385-389","journal-title":"Ann Neurol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/NXG.0000000000000275","volume":"4","author":"Gardiner S.L.","year":"2018","unstructured":"Gardiner S.L.; Milanese C.; Boogaard M.W.; Buijsen R.A.M.; Hogenboom M.; Roos R.A.C.; Mastroberardino P.G.; van Roon-Mom W.M.C.; Aziz N.A.; Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset. Neurol Genet  2018,4(5),275","journal-title":"Neurol Genet"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"Jurcau A.","year":"2023","unstructured":"Jurcau A.; Jurcau C.; Mitochondria in Huntington\u2019s disease: Implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res  2023,18(7),1472-1477","journal-title":"Neural Regen Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10863-014-9593-5","volume":"47","author":"Yonutas H.M.","year":"2015","unstructured":"Yonutas H.M.; Pandya J.D.; Sullivan P.G.; Changes in mitochondrial bioenergetics in the brain versus spinal cord become more apparent with age. J Bioenerg Biomembr  2015,47(1-2),149-154","journal-title":"J Bioenerg Biomembr"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"924","DOI":"10.14336\/AD.2017.1126","volume":"9","author":"Liu F.","year":"2018","unstructured":"Liu F.; Lu J.; Manaenko A.; Tang J.; Hu Q.; Mitochondria in Ischemic Stroke: New Insight and Implications. Aging Dis  2018,9(5),924-937","journal-title":"Aging Dis"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.lfs.2016.09.021","volume":"166","author":"Gibbs W.S.","year":"2016","unstructured":"Gibbs W.S.; Weber R.A.; Schnellmann R.G.; Adkins D.L.; Disrupted mitochondrial genes and inflammation following stroke. Life Sci  2016,166,139-148","journal-title":"Life Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"0079","DOI":"10.34133\/bmr.0079","volume":"28","author":"Zhao Y.","year":"2024","unstructured":"Zhao Y.; Song C.; Wang H.; Gai C.; Li T.; Cheng Y.; Liu J.; Song Y.; Luo Q.; Gu B.; Liu W.; Chai L.; Liu D.; Wang Z.; Polydopamine-cloaked nanoarchitectonics of prussian blue nanoparticles promote functional recovery in neonatal and adult ischemic stroke models. Biomater Res  2024,28,0079","journal-title":"Biomater Res"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","volume":"13","author":"Zhang Y.","year":"2023","unstructured":"Zhang Y.; Zhang H.; Zhao F.; Jiang Z.; Cui Y.; Ou M.; Mei L.; Wang Q.; Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment. Acta Pharm Sin B  2023,13(12),5107-5120","journal-title":"Acta Pharm Sin B"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266397447250723073446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/243978\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266397447250723073446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:33:00Z","timestamp":1765776780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/243978\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":149,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680266397447250723073446","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}